These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 23816504)

  • 1. DRESS syndrome.
    Descamps V; Ranger-Rogez S
    Joint Bone Spine; 2014 Jan; 81(1):15-21. PubMed ID: 23816504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).
    Miyagawa F; Asada H
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.
    Pavlos R; Mallal S; Ostrov D; Pompeu Y; Phillips E
    J Allergy Clin Immunol Pract; 2014; 2(1):21-33. PubMed ID: 24565765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of corticosteroid therapy on viral reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    Tohyama M; Hashimoto K; Oda F; Namba C; Sayama K
    J Dermatol; 2020 May; 47(5):476-482. PubMed ID: 32162382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fatal case of DRESS induced by strontium ranelate associated with HHV-7 reactivation.
    Drago F; Cogorno L; Broccolo F; Ciccarese G; Parodi A
    Osteoporos Int; 2016 Mar; 27(3):1261-1264. PubMed ID: 26519419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis.
    Hama N; Abe R; Gibson A; Phillips EJ
    J Allergy Clin Immunol Pract; 2022 May; 10(5):1155-1167.e5. PubMed ID: 35176506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-reaction eosinophilia and systemic symptoms and drug-induced hypersensitivity syndrome.
    Fernando SL
    Australas J Dermatol; 2014 Feb; 55(1):15-23. PubMed ID: 23866082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
    Cardones AR
    Clin Dermatol; 2020; 38(6):702-711. PubMed ID: 33341203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs.
    Tashiro Y; Azukizawa H; Asada H; Niihara H; Morita E; Yamauchi T; Mizukawa Y; Kusakabe Y; Numazawa S; Izumi M; Sueki H; Watanabe H
    J Dermatol; 2019 Mar; 46(3):226-233. PubMed ID: 30663091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Soluble OX40 as a Diagnostic and Prognostic Biomarker for Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.
    Mitsui Y; Shinkuma S; Nakamura-Nishimura Y; Ommori R; Ogawa K; Miyagawa F; Mori Y; Tohyama M; Asada H
    J Allergy Clin Immunol Pract; 2022 Feb; 10(2):558-565.e4. PubMed ID: 34757063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): a review].
    Ständer S; Metze D; Luger T; Schwarz T
    Hautarzt; 2013 Aug; 64(8):611-22; quiz 623-4. PubMed ID: 23954978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human herpes virus reactivations and dynamic cytokine profiles in patients with cutaneous adverse drug reactions --a prospective comparative study.
    Chen YC; Chiang HH; Cho YT; Chang CY; Chen KL; Yang CW; Lee YH; Chu CY
    Allergy; 2015 May; 70(5):568-75. PubMed ID: 25727950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System.
    Cho YT; Yang CW; Chu CY
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28598363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe graft-versus-host disease-like enterocolitis accompanied with cytomegalovirus-reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    Takamiyagi S; Iriki H; Asahina Y; Furuichi Y; Funakoshi T; Ichikawa M; Mikami Y; Okita H; Sakiyama T; Inazumi T; Amagai M; Takahashi H
    J Dermatol; 2022 Aug; 49(8):796-799. PubMed ID: 35502510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human herpesvirus 6 lymphadenitis in drug rash with eosinophilia and systemic symptoms syndrome: a lymphoma mimic.
    Johnson S; Mathews S; Hudnall SD
    Histopathology; 2017 Jun; 70(7):1166-1170. PubMed ID: 28008656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug reaction with eosinophilia and systemic symptoms, or virus reactivation with eosinophilia and systemic symptoms as a manifestation of immune reconstitution inflammatory syndrome in a patient with HIV?
    Almudimeegh A; Rioux C; Ferrand H; Crickx B; Yazdanpanah Y; Descamps V
    Br J Dermatol; 2014 Oct; 171(4):895-8. PubMed ID: 24773172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 51-Year-Old Woman with Drug-Induced Hypersensitivity Syndrome Associated with Carbamazepine, Reactivation of Human Herpesvirus 6, and Acute Liver Failure: A Case Report.
    Miyasaka A; Kumagai I; Masuda T; Takikawa Y
    Am J Case Rep; 2021 Jan; 22():e928587. PubMed ID: 33504758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).
    Kano Y; Tohyama M; Aihara M; Matsukura S; Watanabe H; Sueki H; Iijima M; Morita E; Niihara H; Asada H; Kabashima K; Azukizawa H; Hashizume H; Nagao K; Takahashi H; Abe R; Sotozono C; Kurosawa M; Aoyama Y; Chu CY; Chung WH; Shiohara T
    J Dermatol; 2015 Mar; 42(3):276-82. PubMed ID: 25623158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saliva polymerase chain reaction assay for detection and follow-up of herpesvirus reactivation in patients with drug reaction with eosinophilia and systemic symptoms (DRESS).
    Descamps V; Avenel-Audran M; Valeyrie-Allanore L; Bensaid B; Barbaud A; Al Jawhari M; Ranger-Rogez S;
    JAMA Dermatol; 2013 May; 149(5):565-9. PubMed ID: 23426332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopathogenic Insights on Preferential Human Herpesvirus-6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms: A Scoping Review.
    Zhu H; Ren V
    J Cutan Med Surg; 2023; 27(4):388-398. PubMed ID: 37231539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.